United States · Startup
United States · Merganser Biotech, Inc.
Merganser Biotech develops and commercializes minihepcidin peptides for the treatment of hemoglobinopathie.
Funding reportedLast round: Undisclosed round
Follow Merganser Biotech, Inc. and see its new rounds in your feed.Start following
What company datasets say Merganser Biotech, Inc. raised
Funding, as reported
Reported in all$28Min dollars
Rounds5
Last roundUndisclosed round
Last round size$28M
Last round dateDec 2016
Investors listed5
Founders and team
From the SEC filings it signed: 2 on the team.
- Brian MacDonaldExecutive Officer, Directori
- Remy SukhijaExecutive Officeri
On the board, as filediColin GoddardJames TopperJeffrey BirdMarkus Goebel
The company, in detail
What they build
Built with from their website
DockerCloudFlare CDNAnsibleCloudflare DNSNode.jsRemote
- Region
- Pennsylvania
- Full record
- Every detail in the company directory
Is this your company?
Add your raise, your deck and your story, and put Merganser Biotech, Inc. in front of investors. Or tell us what we have wrong.